“…Seventeen of the included studies used the BCTQ [ 133 ] for pre- and post-procedural assessment of the severity of the symptoms [ 65 , 66 , 71 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 ]. Significant improvements in the BCTQ symptom severity scale and functional status scale were reported as early as one week after UPCTR [ 78 , 85 , 88 ], and the statistical significance was maintained for up to 2 years [ 82 , 87 ].…”